Is Fortis Healthcare a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Fortis Healthcare Ltd is a below average quality company .

Is Fortis Healthcare undervalued or overvalued?

The key valuation ratios of Fortis Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Fortis Healthcare share price return in the past 10 years?

Fortis Healthcare Ltd share price has appreciated 20.7% annually (CAGR) over the past ten years.

Is Fortis Healthcare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Fortis Healthcare Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

Fortis Healthcare Ltd - Stock Valuation and Financial Performance

Name: Fortis Healthcare
Brand: Fortis Healthcare

BSE: 532843 | NSE: FORTIS | Hospital & Healthcare Services | Mid Cap

Place order

Fortis Healthcare Share Price

₹700.75 22.90 3.38%
as on 03-Dec'24 16:59

10 Year X-Ray of Fortis Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0.9%	0.3%	-0.2%	0.1%	5.1%	8.1%	1.7%	1.3%	2.3%	3.5%	-
Value Creation Index ⓘ	-0.9	-1.0	-1.0	-1.0	-0.6	-0.4	-0.9	-0.9	-0.8	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	611	612	645	659	656	702	633	863	1,053	1,181	1,289
Sales YoY Gr.	-	0.2%	5.5%	2.2%	-0.5%	6.9%	-9.8%	36.3%	22.1%	12.2%	-
Adj EPS ⓘ	-0.4	-0.7	-0.5	-1.3	1.6	6.8	-0.5	-0.2	1.3	2.6	2.1
YoY Gr.	-	NA	NA	NA	NA	320.4%	-107.9%	NA	NA	103.9%	-
BVPS (₹) ⓘ	79.5	80.7	82.1	80.9	110.4	117.6	117.6	117.5	118.7	120.4	120.2
Adj Net Profit ⓘ	-18.8	-32.5	-24.2	-68.1	123	514	-40.5	-13.1	96.7	197	158
Cash Flow from Ops. ⓘ	-144	-761	21.7	-14.8	-61.3	99.9	31.9	76.5	198	218	-
Debt/CF from Ops. ⓘ	-8.6	-1.4	29.8	-37.5	-23.7	7.2	24.4	8.4	1.9	1.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.6%	12.5%	23.1%	12.2%
Adj EPS ⓘ	NA	10%	NA	103.9%
BVPSⓘ	4.7%	1.7%	0.8%	1.4%
Share Price	20.7%	38.4%	35%	82.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-0.5	-0.9	-0.6	-1.6	2	6	-0.5	-0.2	1.1	2.2	1.7
Op. Profit Mgn % ⓘ	-20.4	-20.4	-12.1	-5.7	-18.7	9.8	4.4	13.4	12.7	16.4	18.3
Net Profit Mgn % ⓘ	-3.1	-5.3	-3.8	-10.3	18.7	73.2	-6.4	-1.5	9.2	16.7	12.2
Debt to Equity ⓘ	0.3	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0	0	0
Working Cap Days ⓘ	1,331	1,373	939	536	627	794	756	416	293	213	91
Cash Conv. Cycle ⓘ	17	5	-15	-37	-51	-66	-72	-76	-101	-132	-20

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.70%

Sales growth is growing at healthy rate in last 3 years 23.13%

Sales growth is good in last 4 quarters at 14.62%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Fortis Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2.1	8.7
TTM Sales (₹ Cr.)	1,289	7,313
BVPS (₹.) ⓘ	120.2	103.9
Reserves (₹ Cr.) ⓘ	8,322	7,092
P/BV ⓘ	5.64	6.52
PE ⓘ	324.45	78.03

From the Market
52 Week Low / High (₹)	375.10 / 740.10
All Time Low / High (₹)	45.00 / 740.10
Market Cap (₹ Cr.)	51,175
Equity (₹ Cr.)	755
Face Value (₹)	10
Industry PE ⓘ	41.8

Management X-Ray of Fortis Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Fortis Healthcare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Fortis Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	611	612	645	659	656	702	633	863	1,053	1,181
Operating Expenses ⓘ	759	737	792	697	782	634	605	747	920	989
Manufacturing Costs	298	309	305	313	323	248	220	305	367	386
Material Costs	147	147	151	136	132	147	151	204	265	311
Employee Cost	180	182	190	161	150	155	148	154	175	188
Other Costs ⓘ	134	100	146	87	177	83	87	83	112	103
Operating Profit ⓘ	-149	-126	-147	-38	-125	68	28	115	133	193
Operating Profit Margin (%)	-24.3%	-20.5%	-22.7%	-5.7%	-19.1%	9.7%	4.4%	13.4%	12.6%	16.3%
Other Income ⓘ	218	185	169	138	524	938	192	134	150	143
Interest ⓘ	81	65	106	64	192	160	141	130	106	82
Depreciation ⓘ	27	25	27	29	27	97	111	113	116	101
Exceptional Items ⓘ	3	-18	-4	-68	0	-129	56	-16	48	94
Profit Before Tax ⓘ	-36	-50	-114	-60	180	621	24	-9	109	247
Tax ⓘ	-2	-9	-39	3	57	107	20	4	13	47
Profit After Tax	-34	-40	-75	-64	123	513	4	-13	96	199
PAT Margin (%)	-5.6%	-6.6%	-11.6%	-9.7%	18.7%	73.1%	0.7%	-1.5%	9.1%	16.9%
Adjusted EPS (₹)	-0.7	-0.9	-1.4	-1.2	1.6	6.8	0.1	-0.2	1.3	2.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	78%	38%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3,680	3,735	4,252	4,197	8,337	8,876	8,882	8,869	8,964	9,087
Share Capital ⓘ	463	463	518	519	755	755	755	755	755	755
Reserves ⓘ	3,217	3,272	3,734	3,679	7,582	8,121	8,127	8,114	8,209	8,332
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	597	1,059	625	426	1,421	705	749	639	363	303
Long Term Debt	597	638	183	232	320	621	664	586	282	254
Short Term Debt	0	422	442	194	1,101	84	85	54	81	49
Trade Payables	97	114	140	146	196	212	214	277	416	519
Others Liabilities ⓘ	785	102	77	183	155	937	905	815	570	440
Total Liabilities ⓘ	5,159	5,011	5,094	4,952	10,108	10,730	10,750	10,600	10,312	10,349
Fixed Assets
Gross Block	301	195	234	285	279	1,097	1,152	1,174	947	1,012
Accumulated Depreciation	110	24	49	82	99	191	299	404	456	545
Net Fixed Assetsⓘ	190	172	186	203	180	906	853	770	492	467
CWIP ⓘ	169	182	199	166	165	33	7	6	3	260
Investmentsⓘ	2,411	2,428	3,603	3,658	8,310	8,153	8,898	8,845	8,848	8,834
Inventories	7	6	6	7	6	10	9	14	13	13
Trade Receivables	95	102	76	71	84	81	74	76	97	131
Cash Equivalents	6	9	6	89	33	4	4	1	1	120
Others Assetsⓘ	2,280	2,111	1,020	758	1,331	1,542	906	887	858	523
Total Assets ⓘ	5,159	5,011	5,094	4,952	10,108	10,730	10,750	10,600	10,312	10,349

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-144	-761	22	-15	-61	100	32	76	198	218
PBT ⓘ	-39	-50	-114	-60	180	621	24	-9	109	247
Adjustment ⓘ	-76	-36	-15	44	-288	-553	25	124	28	-47
Changes in Working Capital ⓘ	1	-656	111	-1	99	44	-7	11	96	42
Tax Paid ⓘ	-31	-19	40	2	-52	-11	-10	-49	-34	-23
Cash Flow From Investing Activity ⓘ	294	394	-72	245	-4,688	810	28	238	205	44
Capex	-68	-17	-57	-46	-5	-14	-55	-27	-53	-324
Net Investments	405	-114	221	0	0	20	38	38	46	37
Others ⓘ	-43	526	-236	290	-4,683	804	46	226	212	332
Cash Flow From Financing Activityⓘ	-170	370	45	-292	4,792	-972	6	-320	-395	-245
Net Proceeds from Shares ⓘ	0	2	8	9	4,010	0	92	0	0	0
Net Proceeds from Borrowing ⓘ	-87	0	0	155	17	296	-33	-78	-304	12
Interest Paid ⓘ	-78	-73	-101	-64	-188	-164	-105	-129	-106	-82
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	-75
Others ⓘ	-5	441	139	-392	954	-1,104	52	-113	15	-101
Net Cash Flow ⓘ	-20	3	-5	-62	43	-62	66	-6	8	18

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-0.92	-1.08	-1.87	-1.51	1.96	5.96	0.05	-0.15	1.08	2.21
ROCE (%)	0.9	0.32	-0.16	0.07	5.1	8.05	1.72	1.26	2.28	3.51
Asset Turnover Ratio	0.12	0.12	0.13	0.13	0.09	0.07	0.06	0.08	0.1	0.11
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	-0.5	0.19	8	N/A	2.06	1.1
Working Capital Days
Receivable Days	55	59	50	41	43	43	45	32	30	35
Inventory Days	4	4	3	3	4	4	5	5	5	4
Payable Days	183	262	309	385	473	504	517	439	476	548

Fortis Healthcare Ltd Stock News

Fortis Healthcare Ltd FAQs

What is the share price of Fortis Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of Fortis Healthcare on 03-Dec-2024 16:59 is ₹700.8.

What is the market cap of Fortis Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2024 16:59 the market cap of Fortis Healthcare stood at ₹51,174.8.

What is the P/E ratio of Fortis Healthcare?

The latest P/E ratio of Fortis Healthcare as of 03-Dec-2024 16:59 is 324.4.

What is the P/B ratio of Fortis Healthcare?

The latest P/B ratio of Fortis Healthcare as of 03-Dec-2024 16:59 is 5.64.

What is the 52-week high and low of Fortis Healthcare?

The 52-week high of Fortis Healthcare is ₹740.1 and the 52-week low is ₹375.1.

What is the TTM revenue of Fortis Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fortis Healthcare is ₹1,289 ( Cr.) .

About Fortis Healthcare Ltd

Fortis Healthcare (FHL) incorporated in 1996 is engaged in running chain of hospitals. FHL started its hospital operations in 2001 through its flagship Mohali Hospital. Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities.

On November 13, 2018, IHH Healthcare Berhad, Malaysia acquired 31.10% stake in the Company and appointed majority of board of directors, thereby, becoming the controlling shareholder of the Company.

Business area of the company

The company is a leading integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company holds interests in its subsidiaries, associates and joint ventures which manages and operates a network of multi-specialty hospitals and diagnostics centres.

Awards & Accolades

2016-17

Fortis adjudged ‘Hospital of the Year in India’ and ‘Digital Savvy Hospital of the Year’ at the 2016 APAC Healthcare and Medical Tourism Awards
Fortis Hospital, BG Road, wins ‘Best Medical Tourism Hospital’ Award
Fortis Hospital, Mohali, wins coveted Asia Pacific Hand Hygiene Excellence Award
Fortis Escorts Hospital, Jaipur, wins Quality Council of India recognition for the fourth time in a row
Fortis C-DOC bags ‘Best Diabetic Care Centre in India’ award for the 3rd time in a row
Dr Bidhu K. Mohanti, Director and Head, Radiation Oncology, FMRI, receives Lifetime Achievement Award
Fortis creates history at the CII 17th National Awards for Excellence in Energy Management; four hospitals win top honours
Fortis Hospital, Ludhiana wins Best Multi-speciality Hospital and Best Quality in Service Delivery awards
Fortis Mulund wins two awards each at CIMS Healthcare Excellence and 3rd Asia Healthcare Excellence Awards
Dr Narottam Puri receives Lifetime Achievement Award at FICCI 8th Annual Healthcare Excellence Awards, 2016

2017-18

Team Nursing of Fortis Mulund won two prestigious honours at the 7th International Patient Safety Conference, held in Mumbai
Two Fortis luminaries, Dr Ashok Seth and Dr Ashok Rajgopal, received the prestigious Dr B. C. Roy National Award from the President of India.
The Pharmacy Team at Fortis Hospital, Mulund, has received the 'Pharmacie de Qualite' certification and has been honoured with Platinum rating
Fortis Healthcare won the prestigious 'Gurgaon Best Employer Brand Award 2017
Fortis Hospital, Mulund, won an award for its project, 'One Fortis: Training in Action' at the Asian Hospital Management Awards 2017.
Fortis Hospitals, Bengaluru, bagged three awards, ‘Best Patient Safety Initiative,’ ‘Best CSR Practices in Healthcare’ and ‘Best Use of Social Media and Digital Marketing’ at Times Television Network - National
Marketing Excellence Awards - 2017
Fortis Escorts Hospital, Jaipur, won the National Quality Council of India (QCI) D. L. Shah Award for the fifth time in a row
Fortis Escorts Hospital, Faridabad, was recognised as the 'Best Heart Hospital' at the Double Helical State Health Awards 2017

2018-19

Fortis Hospital, Mulund, earned the JCI re-accreditation for the fifth time in a row
Fortis Healthcare won the ‘Business Process Management (BPM) Asia Master Award’ for the Enterprise level at the BPM Asia Star Championship 2018 organised by CII
Fortis Healthcare received the prestigious FICCI Healthcare Excellence Awards 2018 in the Social Initiative category for the 'Umeed Dhadkan' programme
Fortis Healthcare's MORETOGIVE ad film won a Bronze at the Indian Content Marketing Awards
Fortis Hospital, BG Road, Bengaluru, was ranked by the Medical Travel Quality Alliance (MTQUA) as one of the Top 10 World’s Best Hospitals for Medical Tourism for 2018
For the fifth consecutive year, Fortis C-DOC, New Delhi, was named the ‘Best Hospital in India Diabetic Care’ recognition at the Current Index of Medical Specialities Healthcare Excellence Awards 2018

2019-20

Economic Times Healthworld Hospital Awards’20
FICCI Medical Travel Value Awards 2019
Excellence in Cardiac Sciences
Joint Commission International (JCI) accreditation
National Award for Excellence in Energy Management, 2019
Best Hospital to Work For
International Patient Safety Congress
Most Trusted Diagnostic Centre of the Year

Milestones

2008: Fortis Hospital, Noida Becomes first hospital In Uttar Pradesh to receive the coveted NABH Accredita
2008: Fortis Escorts Becomes First Hospital in Faridabad to Launch Total Knee Replacement Unit
2009: Announces taking over of the operational and management control of the 200-bed Apollo Modi Hospital in Kota (Rajasthan) for providing superior healthcare services in the region.
2009: Launches dental centre at Malar Hospital, Chennai, with the aim of promoting dental tourism in the city. The Fortis Dental Centre has been floated on partnership basis with dental chain Axiss Dental
2010: Completes acquisition of 23.9% stake in Parkway Holdings
2010: Divests entire stake in Parkway to Khazanah
2010: Adds cancer institute in its hospital portfolio
2010: Inks pact with Republic Of Burundi
2010: Inks MOU with RAK Hospital and Tanzania's RMC
2010: Strengthens presence in Central India Network; touches 50 hospitals mark
2010: Acquires O P Jindal Hospital in Raigarh, Chhattisgarh
2010: Unveils new hospital in Shalimar Bagh in Delhi
2010: Adds Vivekanand Hospital to its network
2011: Signs MoU with Utah University for specialized care in emergency medicine
2011: Changes name of company from Fortis Healthcare Ltd to Fortis Healthcare (India) Ltd.
2011: Adds 100 bed Lifeline Hospital at Alwar in Rajasthan,
2011: Fortis Healthcare Ltd acquired Super Religare Laboratories (SRL), South-east Asia's largest diagnostics laboratory network to further strengthen presence across the healthcare value chain
2012: Fortis Healthcare Ltd acquired Fortis Healthcare International Pte. Ltd.-Fortis Healthcare Ltd launched the first colorectal hospital in Singapore, becoming the first Indian hospital chain with a greenfield hospital abroad'
2017: Fortis Healthcare and wayForward collaborate on a unique emotional wellness programme to combat workplace stress
2018: Board of Fortis Healthcare approves the binding investment proposal from IHH Healthcare for an investment of Rs 4,000 crore at a per share price of Rs 170
2019: Fortis join hands with Tips for #Music4MentalHealth Initiative
2019: Fortis School Mental Health Programme initiates internship for students
2020: Fortis rolls out e-Consultations for remote patient care in 23 hospitals across multiple locations in India